COEP
NASDAQ · Biotechnology
Coeptis Therapeutics Holding
$3.94
-0.17 (-4.14%)
Open$4.06
Previous Close$4.11
Day High$4.29
Day Low$3.93
52W High$21.41
52W Low$3.77
Volume—
Avg Volume377.4K
Market Cap102.06M
P/E Ratio—
EPS$-0.88
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.06M | 8.74M | 7.84M |
| Net Income | -17,995,573 | -2,031,310 | -1,359,886 |
| Profit Margin | -874.3% | -23.2% | -17.3% |
| EBITDA | -18,585,812 | -2,389,064 | -2,398,436 |
| Free Cash Flow | — | -1,186,852 | -1,098,506 |
| Rev Growth | — | +14.6% | -0.2% |
| Debt/Equity | 0.02 | 0.28 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |